Surgical Robotics and Navigation Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurosurgery Navigation Market, Spinal Surgical Navigation Market, and 10 more
- Year: 2022
- Scope: 10 Years
- Region: United States
- Pages: 468
- Published Date: 06/17/2022
- Type: MedSuite
Overall, the U.S. surgical navigation market was valued at approximately $548.1 million in 2021. This is expected to increase over the forecast period at a CAGR of 3.6% to reach $703.9 million. On the other hand, the U.S. surgical robotics market was valued at $4.7 billion in 2021. This is expected to increase over the forecast period at a CAGR of 17.6% to reach $14.6 billion.
The full report suite on the U.S. market for robotics and surgical navigation (RNAV) includes four segments in surgical navigation and six segments in robotics. The segmentation for surgical navigation systems includes systems with orthopedic application, spinal surgery application, neurosurgery application, and ENT (ear, nose, throat) application. The segmentation for surgical robotics systems includes minimally invasive surgery (MIS), orthopedic surgery, spinal surgery, neurosurgery, radiosurgery and vascular catheter placement robotic systems.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- COVID-19 Impact Analysis
- 10 Year Scope and Forecast Range
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles and SWOT for Top Competitors
HOW HAS COVID-19 IMPACTED THE U.S. SURGICAL ROBOTICS AND NAVIGATION MARKET?
The effects of the pandemic on the U.S. surgical navigation and robotics market varied by segment. The navigation system market was more heavily impacted as a whole compared to the overall robotics market, likely because more surgeries performed with robotics are considered to be essential, such as radiosurgery. For navigation systems, the segment that experienced the heaviest impact in 2020 was the orthopedic navigation system market.
U.S. SURGICAL ROBOTICS AND NAVIGATION MARKET TRENDS
A general trend that is being observed across all segments of the RNAV market is the shift from hospitals toward alternate care centers. In segments with lower-risk surgeries, such as orthopedic surgery, the shift toward alternate care centers is occurring more rapidly compared to segments with higher-risk surgeries such as neurosurgery or spinal surgery.
U.S. SURGICAL ROBOTICS AND NAVIGATION MARKET SHARE INSIGHTS
Overall, three major companies dominate the U.S. surgical robotics and navigation market – Intuitive Surgical, Smith & Nephew, and Medtronic.
In 2021, Intuitive Surgical continued to dominate the overall surgical robotics market. However, the competitive landscape in the surgical robotics market has been changing steadily in recent years with a number of mergers and acquisitions and new market entrants. Companies such as Asensus Surgical, Auris Health (a subsidiary of Johnson & Johnson), Globus Medical, Medrobotics and Procept BioRobotics entered the market over the last few years.
MARKET SEGMENTATION SUMMARY
- Surgical Navigation Market – Includes:
- Orthopedic navigation systems market, spine navigation systems market, neurosurgery navigation systems market, and the ENT navigation systems market.
- Orthopedic Navigation Systems Market – Includes:
- Orthopedic navigation sensors, capital equipment, LUA and services and maintenance revenue market segments.
- Spine Navigation Systems Market – Includes:
- Capital equipment, LUA and services and maintenance revenue market segments.
- Neurosurgery Navigation Systems Market – Includes:
- Capital equipment, LUA, and services and maintenance revenue market segments.
- ENT Navigation Systems Market – Includes:
- Capital equipment, LUA and services and maintenance revenue market segments.
- Surgical Robotics Market – Includes:
- MIS surgery robotic systems market, robotic-assisted orthopedic surgery systems market, robotic-assisted spinal surgery systems market, robotic-assisted neurosurgery systems market, robotic radiosurgery systems market, and the robotic vascular catheter systems market.
- Minimally Invasive Surgery Robotic Systems Market – Includes:
- Capital equipment segment, the LUA segment and service and maintenance revenue segment.
- Robotic-Assisted Orthopedic Surgery Systems Market – Includes:
- Capital equipment segment, the LUA segment and the service and maintenance revenue market segment.
- Robotic-Assisted Spinal Surgery Systems Market – Includes:
- Capital equipment segment, the LUA segment and the service and maintenance revenue market segment.
- Robotic-Assisted Neurosurgery Systems Market – Includes:
- Capital equipment segment and the service and maintenance revenue market segment.
- Robotic Radiosurgery Systems Market – Includes:
- Capital equipment segment and service and maintenance revenue segment.
- Robotic Vascular Catheter Systems Market – Includes:
- Capital equipment segment, the LUA segment and the services and maintenance revenue segment.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (United States) |
| Base Year | 2021 |
| Forecast | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| U.S. Surgical Navigation and Robotics Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedure Numbers |
| Procedure Codes Investigated |
| Markets Included |
| Key Report Updates |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE U.S. Surgical Navigation and Robotics Market |
| 2.1 Introduction |
| 2.2 Analysis By Market Segment |
| 2.2.1 Worst Case Scenario |
| 2.2.2 Base Case Scenario |
| 2.2.3 Best Case Scenario |
| Disease Overview |
| 3.1 Medical Conditions |
| 3.1.1 Cardiac Conditions |
| 3.1.1.1 Coronary Artery Disease |
| 3.1.1.2 Mitral Valve Prolapse |
| 3.1.2 Colorectal Conditions |
| 3.1.2.1 Colorectal Cancer |
| 3.1.2.2 Diverticulitis |
| 3.1.2.3 Inflammatory Bowel Disease |
| 3.1.3 Digestive Tract Conditions |
| 3.1.3.1 Achalasia |
| 3.1.3.2 Gallbladder Attack |
| 3.1.3.3 Gastroesophageal Reflux Disease |
| 3.1.3.4 Hernia |
| 3.1.3.5 Stomach Cancer |
| 3.1.4 Ear, Nose, and Throat (ENT) Conditions |
| 3.1.4.1 Cholesteatomas |
| 3.1.4.2 Chronic Sinusitis |
| 3.1.4.3 Otitis Media |
| 3.1.4.4 Otosclerosis |
| 3.1.4.5 Tonsillitis |
| 3.1.5 Gynecological Conditions |
| 3.1.5.1 Endometriosis |
| 3.1.5.2 Gynecological Cancers |
| 3.1.5.3 Menorrhagia |
| 3.1.5.4 Pelvic Prolapse |
| 3.1.5.5 Uterine Fibroids |
| 3.1.6 Neurosurgical Conditions |
| 3.1.6.1 Brain Tumor |
| 3.1.6.2 Communicating Hydrocephalus |
| 3.1.6.3 Hydrocephalus |
| 3.1.6.4 Intracranial Aneurysm |
| 3.1.6.5 Intracranial Atherosclerosis Disease |
| 3.1.6.6 Intracranial Pressure |
| 3.1.6.7 Non-Communicating Hydrocephalus |
| 3.1.6.8 Normal Pressure Hydrocephalus |
| 3.1.7 Orthopedic Conditions |
| 3.1.7.1 Arthritis |
| 3.1.7.2 Fractures |
| 3.1.7.3 Osteoporosis |
| 3.1.8 Spinal Conditions |
| 3.1.8.1 Herniated Disc |
| 3.1.8.2 Kyphosis |
| 3.1.8.3 Lordosis |
| 3.1.8.4 Scoliosis |
| 3.1.8.5 Spinal Stenosis |
| 3.1.8.6 Spondylosis |
| 3.1.9 Urological Conditions |
| 3.1.9.1 Benign Prostatic Hyperplasia (BPH) |
| 3.1.9.2 Bladder Cancer |
| 3.1.9.3 Kidney Cancer |
| 3.1.9.4 Prostate Cancer |
| 3.2 Adoption of Robotic-Assisted Procedures |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Surgical Navigation Product Portfolios |
| 4.2.1 Ear, Nose, Throat Surgery |
| 4.2.2 Neurosurgery |
| 4.2.3 Orthopedic Surgery |
| 4.2.4 Spine Surgery |
| 4.3 Robotic-Assisted Surgery Product Portfolios |
| 4.3.1 Minimally Invasive Surgery |
| 4.3.2 Orthopedics |
| 4.3.3 Spine Surgery |
| 4.3.4 Neurosurgery |
| 4.3.5 Radiosurgery |
| 4.3.6 Catheter Placement |
| 4.4 Regulatory Issues and Recalls |
| 4.4.1 Surgical Navigation Regulatory Issues and Recalls |
| 4.4.1.1 Brainlab AG |
| 4.4.1.2 Medtronic |
| 4.4.1.3 Stryker |
| 4.4.1.4 Other |
| 4.4.2 Robotic Assisted Surgery Product Regulatory Issues and Recalls |
| 4.4.2.1 Accuray |
| 4.4.2.2 Brainlab AG |
| 4.4.2.3 Intuitive Surgical |
| 4.4.2.4 Medtronic |
| 4.4.2.1 Siemens Medical Solutions |
| 4.4.2.2 Stryker |
| 4.4.2.3 Zimmer Biomet |
| 4.4.2.4 Other |
| 4.5 Clinical Trials |
| 4.5.1 Surgical Navigation Clinical Trials |
| 4.5.1.1 Aesculap AG |
| 4.5.1.2 Brainlab |
| 4.5.1.3 Medacta |
| 4.5.1.4 Medtronic |
| 4.5.1.6 Stryker |
| 4.5.1.7 Other |
| 4.5.2.3 MicroPort |
| 4.6 Company Profiles |
| 4.6.1 Accuray |
| 4.6.2 Auris Health (J&J) |
| 4.6.3 Brainlab AG |
| 4.6.4 Catheter Precision |
| 4.6.5 Globus Medical |
| 4.6.6 Intuitive Surgical |
| 4.6.7 Medtronic |
| 4.6.8 Siemens Healthineers |
| 4.6.9 Smith & Nephew |
| 4.6.10 Stryker |
| 4.6.11 Zimmer Biomet |
| 4.7 SWOT Analysis |
| 4.7.1 Accuray |
| 4.7.3 Brainlab AG |
| 4.7.4 Catheter Precision |
| 4.7.5 Globus Medical |
| 4.7.6 Intuitive Surgical |
| 4.7.7 Medtronic |
| 4.7.8 Siemens Healthineers |
| 4.7.9 Smith & Nephew |
| 4.7.10 Stryker |
| 4.7.11 Zimmer Biomet |
| Procedure Numbers |
| 5.1 Procedure Codes Investigated |
| 5.2 Procedures |
| 5.2.1 Surgical Navigation Procedures |
| 5.2.1.1 Total Surgical Navigation Procedures |
| 5.2.1.2 Orthopedic Procedures with Surgical Navigation |
| 5.2.1.2.1 Total Knee Arthroplasty (TKA) Procedures with Surgical Navigation |
| 5.2.1.2.2 Partial Knee Arthroplasty (PKA) Procedures with Surgical Navigation |
| 5.2.1.2.3 Total Hip Arthroplasty (THA) Procedures with Surgical Navigation |
| 5.2.1.2.4 Orthopedic Procedures with Surgical Navigation by Anatomy |
| 5.2.1.2.5 Orthopedic Procedures with Surgical Navigation by Care Setting |
| 5.2.1.3 Spinal Procedures with Surgical Navigation |
| 5.2.1.3.1 Spinal Procedures with Surgical Navigation by Type |
| 5.2.1.3.2 Spinal Procedures with Surgical Navigation by Care Setting |
| 5.2.1.4 Neurosurgery Procedures with Surgical Navigation |
| 5.2.1.5 ENT Procedures with Surgical Navigation |
| 5.2.2 Robotic-Assisted Procedures |
| 5.2.2.1 Total Robotic-Assisted Procedures |
| 5.2.2.2 Robotic-Assisted Minimally Invasive Procedures |
| 5.2.2.2.1 Robotic-Assisted Minimally Invasive Procedures by Anatomy |
| 5.2.2.2.2 Robotic-Assisted Minimally Invasive Procedures by Care Setting |
| 5.2.2.3 Robotic-Assisted Orthopedic Procedures |
| 5.2.2.3.1 Robotic-Assisted Total Knee Arthroplasty (TKA) Procedures |
| 5.2.2.3.2 Robotic-Assisted Partial Knee Arthroplasty (PKA) Procedures |
| 5.2.2.3.3 Robotic-Assisted Total Hip Arthroplasty (THA) Procedures |
| 5.2.2.3.4 Robotic-Assisted Orthopedic Procedures by Care Setting |
| 5.2.2.4 Robotic-Assisted Spinal Procedures |
| 5.2.2.4.1 Robotic-Assisted Spinal Fixation Procedures by Anatomy |
| 5.2.2.4.2 Robotic-Assisted Spinal Procedures by Care Setting |
| 5.2.2.5 Robotic-Assisted Neurosurgery Procedures |
| 5.2.2.6 Robotic-Assisted Radiosurgery Procedures |
| 5.2.2.7 Robotic-Assisted Vascular Catheter Placement |
| Surgical Navigation Market Overview |
| 6.1 Introduction |
| 6.1.1 IGS System Components |
| 6.1.2 IGS System Market Segmentation |
| 6.1.3 Limited Use Accessories |
| 6.1.4 Financial Arrangements |
| 6.2 Market Overview and Trend Analysis |
| 6.2.1 Market Overview by Segment |
| 6.2.2 Market Overview by Revenue Type |
| 6.3 Drivers and Limiters |
| 6.3.1 Market Drivers |
| 6.3.2 Market Limiters |
| 6.4 Competitive Market Share Analysis |
| 6.5 Mergers and Acquisitions |
| Orthopedic Navigation System Market |
| 7.1 Introduction |
| 7.1.1 Limited Use Accessories |
| 7.1.2 Financial Arrangements |
| 7.2 Market Overview |
| 7.3 Market Analysis and Forecast |
| 7.3.1 Orthopedic Navigation Sensor Market |
| 7.3.2 Orthopedic Navigation Capital Equipment Market |
| 7.3.2.1 Orthopedic Navigation Capital Equipment Market by Care Setting |
| 7.3.2.1.1 Orthopedic Navigation Hospital Capital Equipment Market |
| 7.3.2.1.2 Orthopedic Navigation Alternate Care Capital Equipment Market |
| 7.3.2.2 Orthopedic Navigation Capital Equipment Market by Size |
| 7.3.2.2.1 Orthopedic Navigation Small Capital Equipment Market |
| 7.3.2.2.2 Orthopedic Navigation Large Capital Equipment Market |
| 7.3.3 Orthopedic Navigation Limited Use Accessories Market |
| 7.3.3.1 Orthopedic Navigation Limited Use Accessories Market by Care Setting |
| 7.3.3.1.1 Orthopedic Navigation Hospital LUA Market |
| 7.3.3.1.2 Orthopedic Navigation Alternate Care LUA Market |
| 7.3.4 Orthopedic Navigation Service and Maintenance Revenue |
| 7.3.5 Orthopedic Navigation System Placements by Financial Arrangements |
| 7.4 Drivers and Limiters |
| 7.4.1 Market Drivers |
| 7.4.2 Market Limiters |
| 7.5 Competitive Market Share Analysis |
| Spine Navigation System Market |
| 8.1 Introduction |
| 8.1.1 Limited Use Accessories |
| 8.1.2 Financial Arrangements |
| 8.2 Market Overview |
| 8.3 Market Analysis and Forecast |
| 8.3.1 Spine Navigation Capital Equipment Market |
| 8.3.1.1 Spine Navigation Capital Equipment Market by Care Setting |
| 8.3.1.1.1 Spine Navigation Hospital Capital Equipment Market |
| 8.3.1.1.2 Spine Navigation Alternate Care Capital Equipment Market |
| 8.3.2 Spine Navigation Limited Use Accessories Market |
| 8.3.2.1 Spine Navigation Limited Use Accessories Market by Care Setting |
| 8.3.2.1.1 Spine Navigation Hospital LUA Market |
| 8.3.2.1.2 Spine Navigation Alternate Care LUA Market |
| 8.3.3 Spine Navigation Service and Maintenance Revenue |
| 8.3.4 Spine Navigation System Placements by Financial Arrangements |
| 8.4 Drivers and Limiters |
| 8.4.1 Market Drivers |
| 8.4.2 Market Limiters |
| 8.5 Competitive Market Share Analysis |
| Neurosurgery Navigation System Market |
| 9.1 Introduction |
| 9.1.1 Limited Use Accessories |
| 9.1.2 Financial Arrangements |
| 9.2 Market Overview |
| 9.3 Market Analysis and Forecast |
| 9.3.1 Neurosurgery Navigation Capital Equipment Market |
| 9.3.1.1 Neurosurgery Navigation Capital Equipment Market by Care Setting |
| 9.3.1.1.1 Neurosurgery Navigation Hospital Capital Equipment Market |
| 9.3.1.1.2 Neurosurgery Navigation Alternate Care Capital Equipment Market |
| 9.3.2 Neurosurgery Navigation Limited Use Accessories Market |
| 9.3.2.1 Neurosurgery Navigation Limited Use Accessories Market by Care Setting |
| 9.3.2.1.1 Neurosurgery Navigation Hospital LUA Market |
| 9.3.2.1.2 Neurosurgery Navigation Alternate Care LUA Market |
| 9.3.3 Neurosurgery Navigation Service and Maintenance Revenue |
| 9.3.4 Neurosurgery Navigation System Placements by Financial Arrangements |
| 9.4 Drivers and Limiters |
| 9.4.1 Market Drivers |
| 9.4.2 Market Limiters |
| 9.5 Competitive Market Share Analysis |
| ENT Navigation System Market |
| 10.1 Introduction |
| 10.1.1 Limited Use Accessories |
| 10.1.2 Financial Arrangements |
| 10.2 Market Overview |
| 10.3 Market Analysis and Forecast |
| 10.3.1 ENT Navigation Capital Equipment Market |
| 10.3.1.1 ENT Navigation Capital Equipment Market by Care Setting |
| 10.3.1.1.1 ENT Navigation Hospital Capital Equipment Market |
| 10.3.1.1.2 ENT Navigation Alternate Care Capital Equipment Market |
| 10.3.2 ENT Navigation Limited Use Accessories Market |
| 10.3.2.1 ENT Navigation Limited Use Accessories Market by Care Setting |
| 10.3.2.1.1 ENT Navigation Hospital LUA Market |
| 10.3.2.1.2 ENT Navigation Alternate Care LUA Market |
| 10.3.3 ENT Navigation Service and Maintenance Revenue |
| 10.3.4 ENT Navigation System Placements by Financial Arrangements |
| 10.4 Drivers and Limiters |
| 10.4.1 Market Drivers |
| 10.4.2 Market Limiters |
| 10.5 Competitive Market Share Analysis |
| Surgical Robotics Market Overview |
| 11.1 Introduction |
| 11.1.1 Limited Use Accessories |
| 11.1.2 Financial Arrangements |
| 11.2 Market Overview and Trend Analysis |
| 11.2.1 Market Overview by Segment |
| 11.2.2 Market Overview by Revenue Type |
| 11.3 Drivers and Limiters |
| 11.3.1 Market Drivers |
| 11.3.2 Market Limiters |
| 11.4 Competitive Market Share Analysis |
| 11.5 Mergers and Acquisitions |
| Minimally Invasive Surgery Robotic System Market |
| 12.1 Introduction |
| 12.1.1 Limited Use Accessories |
| 12.1.2 Financial Arrangements |
| 12.2 Market Overview |
| 12.3 Market Analysis and Forecast |
| 12.3.1 MIS Robotic Capital Equipment Market |
| 12.3.1.1 MIS Robotic Capital Equipment Market by Care Setting |
| 12.3.1.1.1 MIS Robotic Hospital Capital Equipment Market |
| 12.3.1.1.2 MIS Robotic Alternate Care Capital Equipment Market |
| 12.3.2 MIS Robotic Limited Use Accessories Market |
| 12.3.2.1 MIS Robotic Limited Use Accessories Market by Care Setting |
| 12.3.2.1.1 MIS Robotic Hospital LUA Market |
| 12.3.2.1.2 MIS Robotic Alternate Care LUA Market |
| 12.3.3 MIS Robotic Service and Maintenance Revenue |
| 12.3.4 MIS Robotic System Placements by Financial Arrangements |
| 12.4 Drivers and Limiters |
| 12.4.1 Market Drivers |
| 12.4.2 Market Limiters |
| 12.5 Competitive Market Share Analysis |
| 12.5.1 Leading Competitors |
| 12.5.2 Emerging Competitors |
| Robotic-Assisted Orthopedic Surgery System Market |
| 13.1 Introduction |
| 13.1.1 Limited Use Accessories |
| 13.1.2 Financial Arrangements |
| 13.2 Market Overview |
| 13.3 Market Analysis and Forecast |
| 13.3.1 Robotic-Assisted Orthopedic Surgery Capital Equipment Market |
| 13.3.1.1 Robotic-Assisted Orthopedic Surgery Capital Equipment Market by Care Setting |
| 13.3.1.1.1 Robotic-Assisted Orthopedic Surgery Hospital Capital Equipment Market |
| 13.3.1.1.2 Robotic-Assisted Orthopedic Surgery Alternate Care Capital Equipment Market |
| 13.3.2 Robotic-Assisted Orthopedic Surgery Limited Use Accessories Market |
| 13.3.2.1 Robotic-Assisted Orthopedic Surgery Limited Use Accessories Market by Care Setting |
| 13.3.2.1.1 Robotic-Assisted Orthopedic Surgery Hospital LUA Market |
| 13.3.2.1.2 Robotic-Assisted Orthopedic Surgery Alternate Care LUA Market |
| 13.3.3 Robotic-Assisted Orthopedic Surgery Service and Maintenance Revenue |
| 13.3.4 Robotic-Assisted Orthopedic Surgery System Placements by Financial Arrangements |
| 13.4 Drivers and Limiters |
| 13.4.1 Market Drivers |
| 13.4.2 Market Limiters |
| 13.5 Competitive Market Share Analysis |
| 13.5.1 Leading Competitors |
| 13.5.2 Emerging Competitors |
| Robotic-Assisted Spinal Surgery System Market |
| 14.1 Introduction |
| 14.1.1 Limited Use Accessories |
| 14.1.2 Financial Arrangements |
| 14.2 Market Overview |
| 14.3 Market Analysis and Forecast |
| 14.3.1 Robotic-Assisted Spinal Surgery Capital Equipment Market |
| 14.3.1.1 Robotic-Assisted Spinal Surgery Capital Equipment Market by Care Setting |
| 14.3.1.1.1 Robotic-Assisted Spinal Surgery Hospital Capital Equipment Market |
| 14.3.1.1.2 Robotic-Assisted Spinal Surgery Alternate Care Capital Equipment Market |
| 14.3.2 Robotic-Assisted Spinal Surgery Limited Use Accessories Market |
| 14.3.2.1 Robotic-Assisted Spinal Surgery Limited Use Accessories Market by Care Setting |
| 14.3.2.1.1 Robotic-Assisted Spinal Surgery Hospital LUA Market |
| 14.3.2.1.2 Robotic-Assisted Spinal Surgery Alternate Care LUA Market |
| 14.3.3 Robotic-Assisted Spinal Surgery Service and Maintenance Revenue |
| 14.3.4 Robotic-Assisted Spinal Surgery System Placements by Financial Arrangements |
| 14.4 Drivers and Limiters |
| 14.4.1 Market Drivers |
| 14.4.2 Market Limiters |
| 14.5 Competitive Market Share Analysis |
| 14.5.1 Leading Competitors |
| 14.5.2 Emerging Competitors |
| Robotic-Assisted Neurosurgery System Market |
| 15.1 Introduction |
| 15.1.1 Financial Arrangements |
| 15.2 Market Overview |
| 15.3 Market Analysis and Forecast |
| 15.3.2 Robotic-Assisted Neurosurgery Capital Equipment Market |
| 15.3.2.1 Robotic-Assisted Neurosurgery Capital Equipment Market by Care Setting |
| 15.3.2.1.1 Robotic-Assisted Neurosurgery Hospital Capital Equipment Market |
| 15.3.2.1.2 Robotic-Assisted Neurosurgery Alternate Care Capital Equipment Market |
| 15.3.3 Robotic-Assisted Neurosurgery Service and Maintenance Revenue |
| 15.3.4 Robotic-Assisted Neurosurgery System Placements by Financial Arrangements |
| 15.4 Drivers and Limiters |
| 15.4.1 Market Drivers |
| 15.4.2 Market Limiters |
| 15.5 Competitive Market Share Analysis |
| Robotic Radiosurgery System Market |
| 16.1 Introduction |
| 16.1.1 Financial Arrangements |
| 16.2 Market Overview |
| 16.3 Market Analysis and Forecast |
| 16.3.1 Robotic Radiosurgery Capital Equipment Market |
| 16.3.1.1 Robotic Radiosurgery Capital Equipment Market by Care Setting |
| 16.3.1.1.1 Robotic Radiosurgery Hospital Capital Equipment Market |
| 16.3.1.1.2 Robotic Radiosurgery Alternate Care Capital Equipment Market |
| 16.3.2 Robotic Radiosurgery Service and Maintenance Revenue |
| 16.3.3 Robotic Radiosurgery System Placements by Financial Arrangements |
| 16.4 Drivers and Limiters |
| 16.4.1 Market Drivers |
| 16.4.2 Market Limiters |
| 16.5 Competitive Market Share Analysis |
| 16.5.1 Leading Competitors |
| 16.5.2 Emerging Competitors |
| Robotic Vascular Catheter System Market |
| 17.1 Introduction |
| 17.1.1 Limited Use Accessories |
| 17.1.2 Financial Arrangements |
| 17.2 Market Overview |
| 17.3 Market Analysis and Forecast |
| 17.3.1 Robotic Vascular Catheter Capital Equipment Market |
| 17.3.1.1 Robotic Vascular Catheter Capital Equipment Market by Care Setting |
| 17.3.1.1.1 Robotic Vascular Catheter Hospital Capital Equipment Market |
| 17.3.1.1.2 Robotic Vascular Catheter Alternate Care Capital Equipment Market |
| 17.3.2 Robotic Vascular Catheter Limited Use Accessories Market |
| 17.3.2.1 Robotic Vascular Catheter Limited Use Accessories Market by Care Setting |
| 17.3.2.1.1 Robotic Vascular Catheter Hospital LUA Market |
| 17.3.2.1.2 Robotic Vascular Catheter Alternate Care LUA Market |
| 17.3.3 Robotic Vascular Catheter Service and Maintenance Revenue Market |
| 17.3.4 Robotic Vascular Catheter System Placements by Financial Arrangements |
| 17.4 Drivers and Limiters |
| 17.4.1 Market Drivers |
| 17.4.2 Market Limiters |
| 17.5 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · Accelus | · Heal Force |
| · Accuray | · IMRIS Deerfield |
| · Acclarent | · Intellijoint Surgical |
| · Aesculap | · Interventional Systems |
| · ANKE | · Intuitive Surgical |
| · AOT | · Invuity |
| · Asensus Surgical | · Johnson & Johnson |
| · Atracsys | · JointPoint |
| · Augmedics | · KAIST Future Medical Robotics Research Center |
| · Auris Health | · Karl Storz |
| · avateramedical® GmbH | · Kinamed |
| · AVRA Medical | · Koh Young Technology |
| · B. Braun | · KUKA |
| · Blue Belt Technologies | · Medacta |
| · Brainlab | · Medical Surgical Technologies |
| · Bramsys | · Medicaroid |
| · Cardan Robotics | · Medrobotics |
| · Catheter Precision | · Medtech |
| · ClaroNav | · Medtronic |
| · CMR Surgical | · meerecompany |
| · Corin Group | · Memic Innovative Surgery |
| · Corindus Vascular Robotics | · MicroPort Scientific |
| · CUREXO | · Monogram Orthopedics |
| · DePuy Synthes | · Navbit |
| · EndoMaster | · NDI Digital |
| · Ethicon | · Nemaris |
| · ELMED Medical Systems | · NOVADAQ |
| · Exactech | · NuVasive |
| · Fiagon | · Olympus Corporation |
| · Fusion Robotics | · OrthAlign |
| · Getinge | · OrthoGrid |
| · Globus Medical | · Orthokey |
| · Hansen Medical | · OrthoSensor |
List of Charts
| Chart 1‑1: Surgical Navigation Market by Segment, U.S., 2021 – 2028 |
| Chart 1‑2: Surgical Navigation and Robotics Market Overview, U.S., 2021 & 2028 |
| Chart 2‑1: Multi-Scenario Surgical Navigation and Robotics Market Forecast, U.S., 2018 – 2028 (US$M) |
| Chart 5‑1: Surgical Navigation Procedures by Segment, U.S., 2018 – 2028 |
| Chart 5‑2: Robotic-Assisted Procedures by Segment, U.S., 2018 – 2028 |
| Chart 6‑1: Surgical Navigation Market by Segment, U.S., 2018 – 2028 |
| Chart 6‑2: Surgical Navigation Market by Revenue Type, U.S., 2018 – 2028 |
| Chart 6‑3: Leading Competitors, Surgical Navigation Market, U.S., 2021 |
| Chart 7‑1: Orthopedic Navigation System Market by Segment, U.S., 2018 – 2028 |
| Chart 7‑2: Leading Competitors, Orthopedic Navigation System Market, U.S., 2021 |
| Chart 8‑1: Spine Navigation System Market by Segment, U.S., 2018 – 2028 |
| Chart 8‑2: Leading Competitors, Spine Navigation System Market, U.S., 2021 |
| Chart 9‑1: Neurosurgery Navigation System Market by Segment, U.S., 2018 – 2028 |
| Chart 9‑2: Leading Competitors, Neurosurgery Navigation System Market, U.S., 2021 |
| Chart 10‑1: ENT Navigation System Market by Segment, U.S., 2018 – 2028 |
| Chart 10‑2: Leading Competitors, ENT Navigation System Market, U.S., 2021 |
| Chart 11‑1: Surgical Robotics Market by Segment, U.S., 2018 – 2028 |
| Chart 11‑2: Surgical Robotics Market by Revenue Type, U.S., 2018 – 2028 |
| Chart 11‑3: Leading Competitors, Surgical Robotics Market, U.S., 2021 |
| Chart 12‑1: Minimally Invasive Surgery Robotic System Market by Segment, U.S., 2018 – 2028 |
| Chart 12‑2: Leading Competitors, Minimally Invasive Surgery Robotic System Market, U.S., 2021 |
| Chart 13‑1: Robotic-Assisted Orthopedic Surgery System Market by Segment, U.S., 2018 – 2028 |
| Chart 13‑2: Leading Competitors, Robotic-Assisted Orthopedic Surgery Market, U.S., 2021 |
| Chart 13‑3: Leading Competitors, Robotic-Assisted Orthopedic Surgery Market, U.S., 2021 |
| Chart 14‑1: Robotic-Assisted Spinal Surgery System Market by Segment, U.S., 2018 – 2028 |
| Chart 14‑2: Leading Competitors, Robotic-Assisted Spinal Surgery Market, U.S., 2021 |
| Chart 15‑1: Robotic-Assisted Neurosurgery System Market by Segment, U.S., 2018 – 2028 |
| Chart 15‑2: Leading Competitors, Robotic-Assisted Neurosurgery Market, U.S., 2021 |
| Chart 16‑1: Robotic Radiosurgery System Market by Segment, U.S., 2018 – 2028 |
| Chart 17‑1: Robotic Vascular Catheter System Market by Segment, U.S., 2018 – 2028 |
| Chart 17‑2: Leading Competitors, Robotic Catheter System Market, U.S., 2021 |
List of Figures
| Figure 1‑1: Surgical Navigation and Robotics Market Share Ranking by Segment, U.S., 2021 |
| Figure 1‑2: Companies Researched in this Report (1 of 2) |
| Figure 1‑3: Companies Researched in this Report (2 of 2) |
| Figure 1‑4: Factors Impacting the Surgical Navigation and Robotics Market by Segment, U.S. |
| Figure 1‑5: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (1 of 6) |
| Figure 1‑6: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (2 of 6) |
| Figure 1‑7: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (3 of 6) |
| Figure 1‑8: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (4 of 6) |
| Figure 1‑9: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (5 of 6) |
| Figure 1‑10: Recent Events in the Surgical Navigation and Robotics Market, 2018 – 2022 (6 of 6) |
| Figure 1‑11: Surgical Navigation Procedures Covered (1 of 2) |
| Figure 1‑12: Surgical Robotics Procedures Covered (2 of 2) |
| Figure 1‑13: CPT Procedure Codes Investigated (1 of 2) |
| Figure 1‑14: CPT Procedure Codes Investigated (2 of 2) |
| Figure 1‑15: Surgical Navigation Markets Covered (1 of 2) |
| Figure 1‑16: Surgical Navigation Markets Covered (2 of 2) |
| Figure 1‑17: Surgical Robotics Markets Covered (1 of 2) |
| Figure 1‑18: Surgical Robotics Markets Covered (2 of 2) |
| Figure 1‑19: Key Report Updates |
| Figure 1‑20: Version History |
| Figure 2‑1: Surgical Navigation and Robotics Market by Segment, Worst Case Scenario, U.S., 2018 – 2028 (US$M) |
| Figure 2‑2: Surgical Navigation and Robotics Market by Segment, Base Case Scenario, U.S., 2018 – 2028 (US$M) |
| Figure 2‑3: Surgical Navigation and Robotics Market by Segment, Best Case Scenario, U.S., 2018 – 2028 (US$M) |
| Figure 4‑1: ENT Navigation Products by Company |
| Figure 4‑2: Neurosurgery Navigation Products by Company |
| Figure 4‑3: Orthopedic Navigation Products by Company |
| Figure 4‑4: Spine Navigation Products by Company |
| Figure 4‑5: Robot-Assisted Laparoscopy and Flexible Endoscopy Products by Company |
| Figure 4‑6: Robot-Assisted Orthopedic Surgery Products by Company |
| Figure 4‑7: Robot-Assisted Spine Surgery Products by Company |
| Figure 4‑8: Robot-Assisted Neurosurgery Products by Company |
| Figure 4‑9: Robot-Assisted Radiosurgery Products by Company |
| Figure 4‑10: Robot-Assisted Catheter Placement Products by Company |
| Figure 4‑11: Class 2 Device Recall ExacTrac Dynamic Software |
| Figure 4‑12: Class 2 Device Recall ExacTrac Dynamic |
| Figure 4‑13: Class 2 Device Recall Kick Navigation System |
| Figure 4‑14: Class 2 Device Recall Brainlab Cranial Image Guided Surgery System / Instrument, Stereotaxic |
| Figure 4‑15: |
| Figure 4‑16: Class 2 Device Recall Mazor X System (Mazor X Stealth Edition) |
| Figure 4‑17: Class 2 Device Recall NavLock Blue Tracker |
| Figure 4‑18: |
| Figure 4‑19: Class 2 Device Recall Mazor X Stealth Edition Snapshot Orthopedic stereotaxic instrument |
| Figure 4‑20 Class 2 Device Recall Medtronic Navigation |
| Figure 4‑21: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System |
| Figure 4‑22:Class 2 Device Recall Streamline MIS Navigation System |
| Figure 4‑23 Class 2 Device Recall Catalyst System |
| Figure 4‑24: Class 2 Device Recall VERICIS CARDIOVASCULAR IMAGE AND INFORMATION SYSTEM, MODEL 4.0 |
| Figure 4‑25 Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑26: Class 2 Device Recall Intellijoint Navigation System |
| Figure 4‑27: Class 2 Device Recall MRIdian Linac Systems |
| Figure 4‑28: Class 2 Device Recall Exactech GPS Orthopedic stereotaxic instrument |
| Figure 4‑29: Class 2 Device Recall TruDi NAV Suction Instruments |
| Figure 4‑30: Class 2 Device Recall CyberKnife Treatment Delivery System |
| Figure 4‑31: Class 2 Device Recall Mechatronic Vario Guide |
| Figure 4‑32: Class 2 Device Recall da Vinci X/Xi Instrument Arm Drapes |
| Figure 4‑33:Class 2 Device Recall Ion Endoluminal System |
| Figure 4‑34 Class 2 Device Recall da Vinci SP Camera |
| Figure 4‑35: Class 2 Device Recall da Vinci SP Surgical System |
| Figure 4‑36:Class 2 Device Recall da Vinci X Surgical System |
| Figure 4‑37 Class 2 Device Recall daVinci XI Sureform 60 Reload |
| Figure 4‑38: Class 2 Device Recall Medtronic |
| Figure 4‑39:Class 2 Device Recall ARTISTE, MEVATRON, ONCOR, and PRIMUS |
| Figure 4‑40: Class 2 Device Recall Mako Integrated Cutting System (MICS) Handpiece |
| Figure 4‑41: Class 2 Device Recall Mako Hip End Effector |
| Figure 4‑42:Class 2 Device Recall ROSA Brain 3.0 and 3.1 ApplicationBrain |
| Figure 4‑43: Class 2 Device Recall Elekta Harmony Pro, Elekta Infinity, and Elekta Versa HD |
| Figure 4‑44 Class 2 Device Recall Elekta Unity MRLinac, ImageGuided Radiation Therapy System |
| Figure 4‑45: Class 2 Device Recall Elekta Unity |
| Figure 4‑46: Class 2 Device Recall MRIdian Linac System |
| Figure 4‑47: Class 2 Device Recall MRIdian Linac System with 138leaf Collimator |
| Figure 4‑48 Class 2 Device Recall Leksell Vantage Stereotactic System |
| Figure 4‑49: Class 2 Device Recall MRIdian & MRIdian Linac Radiation Therapy System |
| Figure 4‑50: Class 1 Device Recall BrightMatter Guide |
| Figure 4‑51: Orthopilot Elite Post-Market Clinical Follow-Up |
| Figure 4‑52: The Spinal Navigation Trial - Surgical Navigation or Free Hand Technique in Spine Surgery (SPINAV) |
| Figure 4‑53: Medacta NextAR TKA Pivotal Trial |
| Figure 4‑54: Comparing Surgical and Economical Parameters of Total Knee Replacement |
| Figure 4‑55:Medtronic X Versus O-arm Navigation for Pedicle Screw Insertion (RGNV) |
| Figure 4‑56: The European Robotic Spinal Instrumentation (EUROSPIN) Study: A European Prospective Multicenter Multinational Pragmatic Trial on Robot-guided Versus Navigated Versus Freehand Pedicle Screw Fixation |
| Figure 4‑57: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI) |
| Figure 4‑58: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries |
| Figure 4‑59: Evaluation Protocol of the Installation of Knee Unicompartmental Prosthesis (Journey (Smith & Nephew)) With Mechanical Ancillary Versus Robotic Assisted (Navio System). (PUC NAVIO) |
| Figure 4‑60: Navio Robotic Versus Conventional Total Knee Arthroplasty |
| Figure 4‑61: RCT: Mako Medial Unicondylar Knee Arthroplasty vs Oxford Unicondylar Knee Arthroplasty |
| Figure 4‑62:Cardiac Positioning System (CPS) - a Navigation System to Guide Pace Mapping of Ischemic Scar During Catheter Ablation Therapy of Post-myocardial Infarction (MI) Ventricular Tachycardia (VT) in Adults |
| Figure 4‑63: Evaluation of the Accuracy of Surgical Navigation in Spine Instrumentation Using Augmented Reality (HoloNavi) |
| Figure 4‑64: Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation |
| Figure 4‑65: Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations (SCLERONAV) |
| Figure 4‑66: A Randomized Controlled Trial for Patients Underwent Total Hip Arthroplasties Assisted by Surgical Navigation System |
| Figure 4‑67: CyberKnife Radiosurgery for Localized Prostatic Carcinoma |
| Figure 4‑68: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma |
| Figure 4‑69: Patients' Expectations About Effects of Robotic Surgery for Cancer |
| Figure 4‑70: Measuring the Quality of Surgical Care and Setting Benchmarks for Training Using Intuitive Data Recorder Technology (MASTERY) |
| Figure 4‑71: MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology (MARS) |
| Figure 4‑72: Survivorship and Outcomes of Robot Assisted Medial Partial Knee Replacement |
| Figure 4‑73: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement |
| Figure 4‑74: Conventional Total Hip Arthroplasty vs Mako Robotic-arm Assisted Total Hip Arthroplasty |
| Figure 4‑75:Mako Functionally Aligned Total Knee Arthroplasty vs Mako Mechanically Aligned Total Knee Arthroplasty |
| Figure 4‑76: Outcomes of Robotic Total Hip Arthroplasty |
| Figure 4‑77: SWOT Analysis, Accuray |
| Figure 4‑78: SWOT Analysis, Auris Health |
| Figure 4‑79: SWOT Analysis, Brainlab AG |
| Figure 4‑80: SWOT Analysis, Catheter Precision |
| Figure 4‑81: SWOT Analysis, Globus Medical |
| Figure 4‑82: SWOT Analysis, Intuitive Surgical |
| Figure 4‑83: SWOT Analysis, Medtronic |
| Figure 4‑84: SWOT Analysis, Siemens Healthineers |
| Figure 4‑85: SWOT Analysis, Smith & Nephew |
| Figure 4‑86: SWOT Analysis, Stryker |
| Figure 4‑87: SWOT Analysis, Zimmer Biomet |
| Figure 5‑1: CPT Procedure Codes Investigated (1 of 2) |
| Figure 5‑2: CPT Procedure Codes Investigated (2 of 2) |
| Figure 5‑3: Surgical Navigation Procedures by Segment, U.S., 2018 – 2028 |
| Figure 5‑4: Orthopedic Procedures with Surgical Navigation by Anatomy, U.S., 2018 – 2028 |
| Figure 5‑5: Orthopedic Procedures with Surgical Navigation by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑6: Spinal Procedures with Surgical Navigation by Type, U.S., 2018 – 2028 |
| Figure 5‑7: Thoracolumbar Spinal Fixation Navigation Procedures by Type, U.S., 2018 – 2028 |
| Figure 5‑8: Spinal Procedures with Surgical Navigation by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑9: Neurosurgery Procedures with Surgical Navigation by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑10: ENT Procedures with Surgical Navigation by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑11: Robotic-Assisted Procedures by Segment, U.S., 2018 – 2028 |
| Figure 5‑12: Robotic-Assisted Minimally Invasive Procedures by Anatomy, U.S., 2018 – 2028 |
| Figure 5‑13: Robotic-Assisted Minimally Invasive Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑14: Robotic-Assisted Orthopedic Procedures by Anatomy, U.S., 2018 – 2028 |
| Figure 5‑15: Robotic-Assisted Orthopedic Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑16: Robotic-Assisted Spinal Procedures by Anatomy, U.S., 2018 – 2028 |
| Figure 5‑17: Thoracolumbar Spinal Fixation Robotic-Assisted Procedures by Type, U.S., 2018 – 2028 |
| Figure 5‑18: Robotic-Assisted Spinal Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑19: Robotic-Assisted Neurosurgery Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑20: Robotic-Assisted Radiosurgery Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 5‑21: Robotic-Assisted Vascular Catheter Placement Procedures by Care Setting, U.S., 2018 – 2028 |
| Figure 6‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 6‑2: Most Frequently Used Navigation-Specific LUA by Surgical Application |
| Figure 6‑3: Surgical Navigation Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 6‑4: Surgical Navigation Market by Revenue Type, U.S., 2018 – 2028 (US$M) |
| Figure 6‑5: Leading Competitors by Segment, Surgical Navigation Market, U.S., 2021 |
| Figure 7‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 7‑2: Most Frequently Used Orthopedic Navigation LUA |
| Figure 7‑3: Orthopedic Navigation System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 7‑4: Orthopedic Navigation Sensor Market, U.S., 2018 – 2028 |
| Figure 7‑5: Orthopedic Navigation Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 7‑6: Orthopedic Navigation Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑7: Orthopedic Navigation Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 7‑8: Orthopedic Navigation Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 7‑9: Orthopedic Navigation Capital Equipment Market by Size, U.S., 2018 – 2028 (US$M) |
| Figure 7‑10: Orthopedic Navigation Small Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 7‑11: Orthopedic Navigation Large Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 7‑12: Orthopedic Navigation LUA Market, U.S., 2018 – 2028 |
| Figure 7‑13: Orthopedic Navigation LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 7‑14: Orthopedic Navigation Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 7‑15: Orthopedic Navigation Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 7‑16: Orthopedic Navigation Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 7‑17: Orthopedic Navigation System Placements by Financial Arrangements, U.S., 2018 – 2028 |
| Figure 7‑18: Leading Competitors, Orthopedic Navigation System Market, U.S., 2021 |
| Figure 8‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 8‑2: Most Frequently Used Spinal Surgery Navigation LUA |
| Figure 8‑3: Spine Navigation System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 8‑4: Spine Navigation Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 8‑5: Spine Navigation Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 8‑6: Spine Navigation Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 8‑7: Spine Navigation Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 8‑8: Spine Navigation LUA Market, U.S., 2018 – 2028 |
| Figure 8‑9: Spine Navigation LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 8‑10: Spine Navigation Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 8‑11: Spine Navigation Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 8‑12: Spine Navigation Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 8‑13: Spine Navigation System Placements by Financial Arrangements, U.S., 2018 – 2028 |
| Figure 8‑14: Leading Competitors, Spine Navigation System Market, U.S., 2021 |
| Figure 9‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 9‑2: Most Frequently Used Neurosurgery Navigation LUA |
| Figure 9‑3: Neurosurgery Navigation System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 9‑4: Neurosurgery Navigation Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 9‑5: Neurosurgery Navigation Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 9‑6: Neurosurgery Navigation Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 9‑7: Neurosurgery Navigation Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 9‑8: Neurosurgery Navigation LUA Market, U.S., 2018 – 2028 |
| Figure 9‑9: Neurosurgery Navigation LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 9‑10: Neurosurgery Navigation Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 9‑11: Neurosurgery Navigation Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 9‑12: Neurosurgery Navigation Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 9‑13: Neurosurgery Navigation System Placements by Financial Arrangements, U.S., 2018 – 2028 |
| Figure 9‑14: Leading Competitors, Neurosurgery Navigation System Market, U.S., 2021 |
| Figure 10‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 10‑2: Most Frequently Used ENT Navigation LUA |
| Figure 10‑3: ENT Navigation System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 10‑4: ENT Navigation Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 10‑5: ENT Navigation Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 10‑6: ENT Navigation Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 10‑7: ENT Navigation Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 10‑8: ENT Navigation LUA Market, U.S., 2018 – 2028 |
| Figure 10‑9: ENT Navigation LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 10‑10: ENT Navigation Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 10‑11: ENT Navigation Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 10‑12: ENT Navigation Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 10‑13: ENT Navigation System Placements by Financial Arrangements, U.S., 2018 – 2028 |
| Figure 10‑14: Leading Competitors, ENT Navigation System Market, U.S., 2021 |
| Figure 11‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 11‑2: Surgical Robotics Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 11‑3: Surgical Robotics Market by Revenue Type, U.S., 2018 – 2028 (US$M) |
| Figure 11‑4: Leading Competitors by Segment, Surgical Robotics Market, U.S., 2021 |
| Figure 12‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 12‑2: Minimally Invasive Surgery Robotic System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 12‑3: MIS Robotic Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 12‑4: MIS Robotic Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 12‑5: MIS Robotic Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 12‑6: MIS Robotic Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 12‑7: MIS Robotic LUA Market, U.S., 2018 – 2028 |
| Figure 12‑8: MIS Robotic LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 12‑9: MIS Robotic Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 12‑10: MIS Robotic Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 12‑11: MIS Robotic System Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 12‑12: MIS Robotic System Placements by Financial Arrangements U.S., 2018 – 2028 |
| Figure 12‑13: Leading Competitors, Minimally Invasive Surgery Robotic System Market, U.S., 2021 |
| Figure 13‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 13‑2: Robotic-Assisted Orthopedic Surgery System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 13‑3: Robotic-Assisted Orthopedic Surgery Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 13‑4: Robotic-Assisted Orthopedic Surgery Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 13‑5: Robotic-Assisted Orthopedic Surgery Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 13‑6: Robotic-Assisted Orthopedic Surgery Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 13‑7: Robotic-Assisted Orthopedic Surgery LUA Market, U.S., 2018 – 2028 |
| Figure 13‑8: Robotic-Assisted Orthopedic Surgery LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 13‑9: Robotic-Assisted Orthopedic Surgery Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 13‑10: Robotic-Assisted Orthopedic Surgery Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 13‑11: Robotic-Assisted Orthopedic Surgery Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 13‑12: Robotic-Assisted Orthopedic Surgery System Placements by Financial Arrangements U.S., 2018 – 2028 |
| Figure 14‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 14‑2: Robotic-Assisted Spinal Surgery System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 14‑3: Robotic-Assisted Spinal Surgery Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 14‑4: Robotic-Assisted Spinal Surgery Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 14‑5: Robotic-Assisted Spinal Surgery Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 14‑6: Robotic-Assisted Spinal Surgery Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 14‑7: Robotic-Assisted Spinal Surgery LUA Market, U.S., 2018 – 2028 |
| Figure 14‑8: Robotic-Assisted Spinal Surgery LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 14‑9: Robotic-Assisted Spinal Surgery Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 14‑10: Robotic-Assisted Spinal Surgery Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 14‑11: Robotic-Assisted Spinal Surgery Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 14‑12: Robotic-Assisted Spinal Surgery System Placements by Financial Arrangements U.S., 2018 – 2028 |
| Figure 14‑13: Leading Competitors, Robotic-Assisted Spinal Surgery Market, U.S., 2021 |
| Figure 15‑1: Robotic-Assisted Neurosurgery System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 15‑2: Robotic-Assisted Neurosurgery Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 15‑3: Robotic-Assisted Neurosurgery Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 15‑4: Robotic-Assisted Neurosurgery Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 15‑5: Robotic-Assisted Neurosurgery Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 15‑6: Robotic-Assisted Neurosurgery Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 15‑7: Robotic-Assisted Neurosurgery System Placements by Financial Arrangements U.S., 2018 – 2028 |
| Figure 15‑8: Leading Competitors, Robotic-Assisted Neurosurgery Market, U.S., 2021 |
| Figure 16‑1: Robotic Radiosurgery System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 16‑2: Robotic Radiosurgery Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 16‑3: Robotic Radiosurgery Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 16‑4: Robotic Radiosurgery Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 16‑5: Robotic Radiosurgery Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 16‑6: Robotic Radiosurgery Service and Maintenance Revenue, U.S., 2018 – 2028 |
| Figure 16‑7: Robotic Radiosurgery System Placements by Financial Arrangements, U.S., 2018 – 2028 |
| Figure 16‑8: Leading Competitors, Robotic Radiosurgery System Market, U.S., 2021 |
| Figure 17‑1: Limited Use Accessories (LUA) Market Segment |
| Figure 17‑2: Robotic Vascular Catheter System Market by Segment, U.S., 2018 – 2028 (US$M) |
| Figure 17‑3: Robotic Vascular Catheter Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 17‑4: Robotic Vascular Catheter Capital Equipment Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 17‑5: Robotic Vascular Catheter Hospital Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 17‑6: Robotic Vascular Catheter Alternate Care Capital Equipment Market, U.S., 2018 – 2028 |
| Figure 17‑7: Robotic Vascular Catheter LUA Market, U.S., 2018 – 2028 |
| Figure 17‑8: Robotic Vascular Catheter LUA Market by Care Setting, U.S., 2018 – 2028 (US$M) |
| Figure 17‑9: Robotic Vascular Catheter Hospital LUA Market, U.S., 2018 – 2028 |
| Figure 17‑10: Robotic Vascular Catheter Alternate Care LUA Market, U.S., 2018 – 2028 |
| Figure 17‑11: Robotic Vascular Catheter Service and Maintenance Revenue Market, U.S., 2018 – 2028 |
| Figure 17‑12: Robotic Vascular Catheter System Placements by Financial Arrangements U.S., 2018 – 2028 |
| Figure 17‑13: Leading Competitors, Robotic Catheter System Market, U.S., 2021 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Surgical Robotics and Navigation Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurosurgery Navigation Market, Spinal Surgical Navigation Market, and 10 more
$295 – $9,995
iData’s U.S. Surgical Robotics MedSuite covers 12 markets including the neurosurgery navigation market and spinal surgical navigation market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
- 2022
- 10 Years
- United States
- 06/17/2022
- MedSuite
- 468
Related Reports
